Final Guidance Ref. 8 - Evaluaton of Infant Formula Protein Quality - Comparison of in vitro with in vivo methods
FDA-2022-D-2424-0022Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Final Guidance Ref. 8 - Evaluaton of Infant Formula Protein Quality - Comparison of in vitro with in vivo methods
- Posted
- May 22, 2026
- Topics
